J. Neurochem. 95 (4), 919-929. https://doi.org/10.1111/j.1471-4159.2005.03395.d.

Savio, L.E.B., de Andrade Mello, P., da Silva, C.G., Coutinho-Silva, R., 2018. The P2X7 receptor in inflammatory diseases: angel or demon? Front. Pharmacol. 9, 52. https://doi.org/10.3389/fphar.2018.00052.

Schiffmann, S.N., Fisone, G., Moresco, R., Cunha, R.A., Ferré, S., 2007. Adenosine A2A receptors and basal ganglia physiology. Prog. Neurobiol. 83 (5), 277-292. https://doi.org/10.1016/j.pneurobio.2007.05.001.

Schiffmann, S.N., Vanderhaeghen, J.J., 1993. Adenosine A2 receptors regulate the gene expression of striatonalpallidal and striatonigral neurons. J. Neurosci.: Off. J. Soc. Neurosci. 13 (3), 1080-1087.

Schneider, M., Prudic, K., Pippel, A., Klapperstück, M., Braam, U., Müller, C.E., Schmalzing, G., Markwardt, F., 2017. Interaction of Purinergic P2X4 and P2X7 Receptor Subunits. Front. Pharmacol. 8. (https://www.frontiersin.org/articles/10.3389/fphar.2017.00860).

Schreiner, T.G., Romanescu, C., Popescu, B.O., 2022. The blood-brain barrier—a key player in multiple sclerosis disease mechanisms (Article). Biomolecules 12 (4), 4. https://doi.org/10.3390/biom12040538.

Seguela, P., Haghighi, A., Soghomonian, J.A., Cooper, E., 1996. A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain. J. Neurosci. 16 (2), 448-455. https://doi.org/10.1523/JNEUROSCI.16-02-00448.1996.

Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M.-L., Grognet, P., Bombois, S., Blum, D., Delacourte, A., Pasquier, F., Vanmechelen, E., Schraen-Maschke, S., Buée, L., 2008. Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteom. 5 (2), 207-224. https://doi.org/10.1586/14789450.5.2.207.

Sharp, A.J., Polak, P.E., Simonini, V., Lin, S.X., Richardson, J.C., Bongarzone, E.R., Feinstein, D.L., 2008. P2X7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J. Neuroinflamm. 5 (1), 33. https://doi.org/10.1186/1742-2094-5-33.

Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., 2015. Cleavage of GSMD by inflammatory caspases determines pyroptotic cell death. Nature 526 (7575), 660-665. https://doi.org/10.1038/nature15514.

Shiratori, M., Tozaki-Saitoh, H., Yoshitake, M., Tsuda, M., Inoue, K., 2010. P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways: P2X7 mediated CXCL2 release. J. Neurochem. 114 (3), 810-819. https://doi.org/10.1111/j.1471-4159.2010.06809.x.

Silberberg, S.D., Li, M., Swartz, K.J., 2007. Ivermectin Interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron 54 (2), 263-274. https://doi.org/10.1016/j.neuron.2007.03.020.

Sim, J.A., Chaumont, S., Jo, J., Ulmann, L., Young, M.T., Cho, K., Buell, G., North, R.A., Rassendren, F., 2006. Altered hippocampal synaptic potentiation in P2X4 knock-out mice. J. Neurosci.: Off. J. Soc. Neurosci. 26 (35), 9006-9009. https://doi.org/10.1523/JNEUROSCI.2370-06.2006.

Skaper, S.D., Facci, L., Culbert, A.A., Evans, N.A., Chessell, I., Davis, J.B., Richardson, J. C., 2006. P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro. Glia 54 (3), 234-242. https://doi.org/10.1002/glia.20379.

Smith, K.M., Browne, S.E., Jayaraman, S., Bleickardt, C.J., Hodge, L.M., Lis, E., Yao, L., Rittle, S.L., Innocent, N., Mullins, D.E., Boykow, G., Reynolds, I.J., Hill, D., Parker, E. M., Hodgson, R.A., 2014. Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice. Eur. J. Pharmacol. 728, 31-38. https://doi.org/10.1016/j.ejphar.2014.01.052.

Solle, M., Labasi, J., Perregaux, D.G., Stam, E., Petrushova, N., Koller, B.H., Griffiths, R. J., Gabel, C.A., 2001. Altered cytokine production in mice lacking P2X7 receptors. J. Biol. Chem. 276 (1), 125-132. https://doi.org/10.1074/jbc.M006781200.

Soni, S., O'Dea, K.P., Tan, Y.Y., Cho, K., Abe, E., Romano, R., Cui, J., Ma, D., Sarathachandra, P., Wilson, M.R., Takata, M., 2019. ATP redacts cytokine trafficking and promotes novel membrane TNF signaling via microvesicles. FASEB J. 33 (5), 6442-6455. https://doi.org/10.1096/molecules.201802386.

Soto, F., Garcia-Guzman, M., Gomez-Hernandez, J.M., Hollmann, M., Karschin, C., Stühmer, W., 1996. P2X4: An ATP-activated ionotonic receptor cloned from rat brain. Proc. Natl. Acad. Sci. USA 93 (8), 3684-3688. https://doi.org/10.1073/pnas.93.8.3684.

Stockwell, J., Jakova, E., Cayabyab, F.S., 2017. Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration. Molecules 22 (4), E676. https://doi.org/10.3390/molecules22040676.

Stojilkovic, S.S., Zemkova, H., 2013. P2X receptor channels in endocrine glands. Wiley Intersdisc. Rev. Membr. Transp. Signal. 2 (4), 173-180. https://doi.org/10.1002/wms.89.

Stokes, L., 2013. Rab5 regulates internalisation of P2X4 receptors and potentiation by ivermectin. Purinergic Signal. 9 (1), 113-121. https://doi.org/10.1007/s11302-012-9336-1.

Stokes, L., Layhadi, J.A., Bibic, L., Dhuna, K., Fountain, S.J., 2017. P2X4 receptor function in the nervous system and current breakthroughs in pharmacology. Front. Pharmacol. 8. (https://www.frontiersin.org/articles/10.3389/fphar.2017.00291).

Suprenant, A., Rassendren, F., Kawashima, E., North, R.A., Buell, G., 1996. The Cytolytic P<sub>22</sub> receptor for extracellular ATP identified as a P<sub>2X</sub> Receptor (P2X<sub>7</sub>). Science 272 (5262), 735-738. https://doi.org/10.1126/science.272.5262.735.

Suurväli, J., Boudinot, P., Kanelopoulos, J., Rüütel Boudinot, S., 2017. P2X4: a fast and sensitive purinergic receptor. Biomed. J. 40 (5), 245-256. https://doi.org/10.1016/j.bj.2017.06.010.

Suzuki, T., 2004. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J. Neurosci. 24 (1), 1-7. https://doi.org/10.1523/JNEUROSCI.3792-03.2004.

Tan, S.-L., Barri, M., Atakpa-Adaji, P., Taylor, C.W., St. John Smith, E., Murrell-Lagnado, R.D., 2021. P2X4 receptors mediate Ca2+ release from lysosomes in

response to stimulation of P2X7 and H1 histamine receptors. Int. J. Mol. Sci. 22 (19), 10492. https://doi.org/10.3390/ijms221910492.

Tan, Y., Zhao, B., Zeng, Q.-C., Shi, C.-M., Zhao, F.-B., Li, Z.-W., 2009. Characteristics of ATP-activated current in nodose ganglion neurons of rats. Neurosci. Lett. 459 (1), 25-29. https://doi.org/10.1016/j.neulet.2009.04.054.

Tarditi, A., Camurri, A., Varani, K., Borea, P.A., Woodman, B., Bates, G., Cattaneo, E., Abbracchio, M.P., 2006. Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease. Neurobiol. Dis. 23 (1), 44-53. https://doi.org/10.1016/j.nbd.2006.01.014.

Taticheff, S., Kebede, A., Buto, T., Werkeneh, W., Tilahun, D., 1994. Effect of ivermectin (Mectizan) on intestinal nematodes. Ethiop. Med. J. 32 (1), 7-15.

Tebano, M.T., Martire, A., Rebola, N., Pepponi, R., Domenici, M.R., Grò, M.C., Schwarzschild, M.A., Chen, J.F., Cunha, R.A., Popoli, P., 2005. Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects. J. Neurochem. 95 (4), 1188-1200. https://doi.org/10.1111/j.1471-4159.2005.03455.x.

Temido-Ferreira, M., Ferreira, D.G., Batalha, V.L., Marques-Morgado, I., Coelho, J.E., Pereira, P., Gomes, R., Pinto, A., Carvalho, S., Canas, P.M., Cuvelier, L., Buée-Scherrer, V., Faivre, E., Baqi, Y., Müller, C.E., Pimentel, J., Schiffmann, S.N., Buée, L., Bader, M., Lopes, L.V., 2020a. Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGLUr5 and NMDA receptors. Mol. Psychiatry 25 (8), 1876-1900. https://doi.org/10.1038/s41380-018-01109-9.

Tetzlaff, W., Schubert, P., Kreutzberg, G.W., 1987. Synaptic and extrasynaptic localization of adenosine binding sites in the rat hippocampus. Neuroscience 21 (3), 869-875. https://doi.org/10.1016/0306-4522(87)90043-1.

Thawkar, B.S., Kaur, G., 2019. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease. J. Neuroimmunol. 326, 62-74. https://doi.org/10.1016/j.jneuim.2018.11.010.

Toloe, J., Mollajew, R., Kügler, S., Mironov, S.L., 2014. Metabolic differences in hippocampal 'Rett' neurons revealed by ATP imaging. Mol. Cell. Neurosci. 59, 47-56. https://doi.org/10.1016/j.mcn.2013.12.008.

Tortelli, R., Zecca, C., Piccininni, M., Bennahamed, S., Dell'Abate, M.T., Barulli, M.R., Capozzo, R., Battista, P., Logroscino, G., 2020. Plasma inflammatory cytokines are elevated in ALS. Front. Neurol. 11. (https://www.frontiersin.org/articles/10.3389/feur.2020.552295).

Tóth, A., Antal, Z., Berezcki, D., Sperlagh, B., 2019. Purinergic signalling in Parkinson's disease: a multi-target system to combat neurodegeneration. Neurochem. Res. 44 (10), 2413-2422. https://doi.org/10.1007/s11064-019-02798-1.

Trautmann, A., 2009. Extracellular ATP in the immune system: more than just a «Danger Signal». pe6-pek6 Sci. Signal. 2 (56). https://doi.org/10.1126/scisignal.256pe6.

Trinh, P.N.H., Baltos, J.-A., Hellyer, S.D., May, L.T., Gregory, K.J., 2022. Adenosine receptor signalling in Alzheimer's disease. Purinergic Signal. 18 (3), 359-381. https://doi.org/10.1007/s11302-022-09883-1.

Troncoso-Escudero, P., Parra, A., Nassif, M., Vidal, R.L., 2018. Outside in: unraveling the role of neuroinflammation in the progression of Parkinson's disease. Front. Neurol. 9, 860. https://doi.org/10.3389/feur.2018.00860.

Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M.W., Inoue, K., 2003. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (6950), 778-783. https://doi.org/10.1038/nature01786.

Twum-Danso, N.A., 2003. Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases. Filaria J. 2 (1), S3. https://doi.org/10.1186/1475-2883-2-S1-S3.

Tyebji, S., Saavedra, A., Canas, P.M., Pliassova, E., Delgado-García, J.M., Alberch, J., Cunha, R.A., Guartu, A., Pérez-Navarro, E., 2015. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease. Neurobiol. Dis. 74, 41-57. https://doi.org/10.1016/j.nbd.2014.11.004.

Ullah, F., Ali, T., Ullah, N., Kim, M.O., 2015. Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain. Neurochem. Int. 90, 114-124. https://doi.org/10.1016/j.neint.2015.07.001.

Ulmann, L., Hatcher, J.P., Hughes, J.P., Chaumont, S., Green, P.J., Conquet, F., Buell, G. N., Reeve, A.J., Chessell, I.P., Rassendren, F., 2008. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci.: Off. J. Soc. Neurosci. 28 (44), 11263-11268. https://doi.org/10.1523/JNEUROSCI.2308-08.2008.

Ulmann, L., Hirbec, H., Rassendren, F., 2010. P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 29 (14), 2290-2300. https://doi.org/10.1038/emboj.2010.126.

Ulmann, L., Levavasseur, F., Avignone, E., Peyroutou, R., Hirbec, H., Audinat, E., Rassendren, F., 2013. Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus. Glia 61 (8), 1306-1319. https://doi.org/10.1002/glia.22516.

Varani, K., Rigamonti, D., Sipione, S., Camurri, A., Borea, P.A., Cattabeni, F., Abbracchio, M.P., Cattaneo, E., 2001. Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 15 (7), 1245-1247.

Varma, R., Chai, Y., Troncoso, J., Gu, J., Xing, H., Stojilkovic, S.S., Mattson, M.P., Haughey, N.J., 2009. Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity. Neuromol. Med. 11 (2), 63-75. https://doi.org/10.1007/s12017-009-8073-2.

Vavra, V., Bhattacharya, A., Zemkova, H., 2011. Facilitation of glutamate and GABA release by P2X receptor activation in supraoptic neurons from freshly isolated rat
brain slices. Neuroscience 188, 1–12. https://doi.org/10.1016/j.neuroscience.2011.04.067

Vázquez-Villoldo, N., Domercq, M., Martín, A., Llop, J., Gómez-Vallejo, V., Matute, C., 2014. P2X4 receptors control the fate and survival of activated microglia. Glia 62 (2), 171–184. https://doi.org/10.1002/glia.22596.

Viana da Silva, S., Haberl, M.G., Zhang, P., Bethge, P., Lemos, C., Gonçalves, N., Gorlewicz, A., Malezieux, M., Gonçalves, F.Q., Grosjean, N., Blanchet, C., Frick, A., Nägerl, U.V., Cunha, R.A., Mulle, C., 2016. Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors. Nat. Commun. 7, 11915. https://doi.org/10.1038/ncomms11915.

Villar-Menéndez, I., Blanch, M., Tyebji, S., Pereira-Veiga, T., Albasanz, J.L., Martín, M., Ferrer, I., Pérez-Navarro, E., Barrachina, M., 2013. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease. Neuromol. Med. 15 (2), 295–309. https://doi.org/10.1007/s12017-013-8219-0.

Virgilio, F.D., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J.M., Venketaraman, V., Baricordi, O.R., 1998. Cytolytic P2X purinoceptors. Cell Death Differ. 5 (3), 191–199. https://doi.org/10.1038/sj.cdd.4400341.

Volonté, C., Amadio, S., Fabbrizio, P., Apolloni, S., 2019. Functional microglia neurotransmitters in amyotrophic lateral sclerosis. Semin. Cell Dev. Biol. 94, 121–128. https://doi.org/10.1016/j.semcdb.2019.04.014.

Wang, X., Arcuino, G., Takano, T., Lin, J., Peng, W.G., Wan, P., Li, P., Xu, Q., Liu, Q.S., Goldman, S.A., Nedergaard, M., 2004. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10 (8), 821–827. https://doi.org/10.1038/nm1082.

Wang, X.-H., Xie, X., Luo, X.-G., Shang, H., He, Z.-Y., 2017. Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease. Neural Regen. Res. 17 (4), 898–904. https://doi.org/10.4103/1673-5374.323077.

Wang, J., Zhang, X.-N., Fang, J.-N., Hua, F.-F., Han, J.-Y., Yuan, Z.-Q., Xie, A.-M., 2021. The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson's disease. Neural Regen. Res. 17 (4), 898–904. https://doi.org/10.3892/mmр.2016.6070.

Wang, J., Zhang, X.-N., Fang, J.-N., Hua, F.-F., Han, J.-Y., Yuan, Z.-Q., Xie, A.-M., 2022. The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson's disease. Neural Regen. Res. 17 (4), 898–904. https://doi.org/10.4103/1673-5374.323077.

Weintraub, D., Aarsland, D., Chaudhuri, K.R., Dobkin, R.D., Leentjens, A.F., Rodriguez-Violante, M., Schrag, A., 2022. The neuropsychiatry of Parkinson's disease: Advances and challenges. Lancet Neurol. 21 (1), 89–102. https://doi.org/10.1016/S1474-4422(21)00330-6.

Xiao, D., Bastia, E., Xu, Y.-H., Benn, C.L., Cha, J.-H.J., Peterson, T.S., Chen, J.-F., Schwarzschild, M.A., 2006. Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice. J. Neurosci.: Off. J. Soc. Neurosci. 26 (52), 13548–13555. https://doi.org/10.1523/JNEUROSCI.3554-06.2006.

Xu, J., Bernstein, A.M., Wong, A., Lu, X.-H., Khoja, S., Yang, X.W., Davies, D.L., Micevych, P., Sofroniew, M.V., Khakh, B.S., 2016. P2X4 receptor reporter mice: sparse brain expression and feeding-related presynaptic facilitation in the arcuate nucleus. J. Neurosci. 36 (34), 8902–8920. https://doi.org/10.1523/JNEUROSCI.1496-16.2016.

Xu, M.-X., Zhao, G.-L., Hu, X., Zhou, H., Li, S.-Y., Li, F., Miao, Y., Lei, B., Wang, Z., 2022. P2X7/P2X4 receptors mediate proliferation and migration of retinal microglia in experimental glaucoma in mice. Neurosci. Bull. 38 (8), 901–915. https://doi.org/10.1007/s12264-022-00833-w.

Yamamoto, K., Sokabe, T., Matsumoto, T., Yoshimura, K., Shibata, M., Ohura, N., Fukuda, T., Sato, T., Sekine, K., Kato, S., Isshiki, M., Fujita, T., Kobayashi, M., Kawamura, K., Masuda, H., Kamiya, A., Ando, J., 2006. Impaired flow-dependent

control of vascular tone and remodeling in P2X4-deficient mice (Article). Nat. Med. 12 (1), 1. https://doi.org/10.1038/nm1338.

Yang, A., Sonin, D., Jones, L., Barry, W.H., Liang, B.T., 2004. A beneficial role of cardiac P2X4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 287 (3), H1096–H1103. https://doi.org/10.1152/ajpheart.00079.2004.

Yang, Q., Wang, G., Zhang, F., 2020. Role of peripheral immune cells-mediated inflammation on the process of neurodegenerative diseases. Front. Immunol. 11. https://www.frontiersin.org/articles/10.3389/fimmu.2020.582825.

Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I.P., Naylor, A., Bountra, C., Banati, R. R., Anand, P., 2006. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 6 (1), 12. https://doi.org/10.1186/1471-2377-6-12.

Young, C.N.J., Górecki, D.C., 2018. P2RX7 purinoceptor as a therapeutic target—the second coming? Front. Chem. 6, 248. https://doi.org/10.3389/fchem.2018.00248.

Yu, L., Shen, H.-Y., Coelho, J.E., Araújo, I.M., Huang, Q.-Y., Day, Y.-J., Rebola, N., Canas, P.M., Rapp, E.K., Ferrara, J., Taylor, D., Müller, C.E., Linden, J., Cunha, R.A., Chen, J.-F., 2008a. Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann. Neurol. 63 (3), 338–346. https://doi.org/10.1002/ana.21313.

Yu, Y., Ugawa, S., Ueda, T., Ishida, Y., Inoue, K., Kyaw Nyunt, A., Umemura, A., Mase, M., Yamada, K., Shimada, S., 2008b. Cellular localization of P2X7 receptor mRNA in the rat brain. Brain Res. 1194, 45–55. https://doi.org/10.1016/j.brainres.2007.11.064.

Zabala, A., Vázquez-Villoldo, N., Rissiek, B., Gejo, J., Martin, A., Palomino, A., Perez-Samartín, A., Pulagam, K.R., Lukowiak, M., Capetillo-Zarate, E., Llop, J., Magnus, T., Koch-Nolte, F., Rassendren, F., Matute, C., Domercq, M., 2018. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis. EMBO Mol. Med. 10 (8). https://doi.org/10.15252/emmm.201708743.

Zhang, Z., Chen, G., Zhou, W., Song, A., Xu, T., Luo, Q., Wang, W., Gu, X., Duan, S., 2007. Regulated ATP release from astrocytes through lysosome exocytosis (Article). Nat. Cell Biol. 9 (8), 8. https://doi.org/10.1038/ncb1620.

Zhang, X., Wang, J., Gao, J.-Z., Zhang, X.-N., Dou, K.-X., Shi, W.-D., Xie, A.-M., 2021. P2X4 receptor participates in autophagy regulation in Parkinson's disease. Neural Regen. Res. 16 (12), 2505–2511. https://doi.org/10.4103/1673-5374.313053.

Zhang, T., Zhang, M., Cui, S., Liang, W., Jia, Z., Guo, F., Ou, W., Wu, Y., Zhang, S., 2023. The core of maintaining neuropathic pain: crosstalk between glial cells and neurons (neural cell crosstalk at spinal cord). Brain Behav. 13 (2), e2868. https://doi.org/10.1002/brb3.2868.

Zhao, Z.-A., Li, P., Ye, S.-Y., Ning, Y.-L., Wang, H., Peng, Y., Yang, N., Zhao, Y., Zhang, Z.-H., Chen, J.-F., Zhou, Y.-G., 2017. Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation. Sci. Rep. 7 (1), 2254. https://doi.org/10.1038/s41598-017-02505-6.

Zhao, W., Ma, L., Cai, C., Gong, X., 2019. Caffeine Inhibits NLRP3 inflammasome activation by suppressing MAPK/NF-κB and A2A2 signaling in LPS-induced THP-1 macrophages. Int. J. Biol. Sci. 15 (8), 1571–1581. https://doi.org/10.7150/ijbs.34211.

Zhao, Z.-A., Zhao, Y., Ning, Y.-L., Yang, N., Peng, Y., Li, P., Chen, X.-Y., Liu, D., Wang, H., Chen, X., Bai, W., Chen, J.-F., Zhou, Y.-G., 2017. Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation. Transl. Psychiatry 7 (5), e1123. https://doi.org/10.1038/tp.2017.98.

Zimmermann, H., 2021. History of ectonucleotidases and their role in purinergic signaling. Biochem. Pharmacol. 187, 114322. https://doi.org/10.1016/j.bcp.2020.114322.